Monopar Therapeutics(MNPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MNPR Monopar Therapeutics

Not Yet Opened 07-02 16:00:00 EDT

97.79

+2.76

+2.90%

盘后97.79

+0.000.00%

17:08 EDT

High100.00	Low93.59	Vol188.27K
Open95.44	D1 Closing95.03	Amplitude6.75%
Mkt Cap653.49M	Tradable Cap482.26M	Total Shares6.68M
T/O18.22M	T/O Rate3.82%	Tradable Shares4.93M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MNPR","market":"US","secType":"STK","nameCN":"Monopar Therapeutics","latestPrice":97.79,"timestamp":1783022400000,"preClose":95.03,"halted":0,"volume":188267,"hourTrading":{"tag":"盘后","latestPrice":97.79,"preClose":97.79,"latestTime":"17:08 EDT","volume":696,"amount":67999.44,"timestamp":1783026514946,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02904345996001268,"floatShares":4931541,"shares":6682584,"eps":-1.921609,"marketStatus":"Not Yet Opened","change":2.76,"latestTime":"07-02 16:00:00 EDT","open":95.44,"high":100,"low":93.59,"amount":18221926.15056,"amplitude":0.067452,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.921609,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":0,"adr":0,"listingDate":1576731600000,"exchange":"NASDAQ","adjPreClose":95.03,"postHourTrading":{"tag":"盘后","latestPrice":97.79,"preClose":97.79,"latestTime":"17:08 EDT","volume":696,"amount":67999.44,"timestamp":1783026514946,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0203277534240407},"requestUrl":"/m/hq/s/MNPR/wiki","defaultTab":"wiki","newsList":[{"id":"2648451739","title":"Monopar Therapeutics price target raised to $117 from $104 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2648451739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648451739?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:00","pubTimestamp":1782903616,"startTime":"0","endTime":"0","summary":"BTIG analyst Jeet Mukherjee raised the firm’s price target on Monopar Therapeutics (MNPR) to $117 from $104 and keeps a Buy rating on the shares. M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/monopar-therapeutics-price-target-raised-to-117-from-104-at-btig-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/monopar-therapeutics-price-target-raised-to-117-from-104-at-btig-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562495","title":"Monopar Therapeutics Director Nicole Sweeny Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562495","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562495?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:58","pubTimestamp":1782853087,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics director Nicole Sweeny files initial beneficial ownership statementMonopar Therapeutics director Nicole Sweeny filed an initial Form 3 on June 30 tied to her June 22 appointment.D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL9MkyrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647445553","title":"Monopar Says FDA Grants Rare Pediatric Disease Designation for Alxn1840 in Wilson Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2647445553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647445553?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:02","pubTimestamp":1782820933,"startTime":"0","endTime":"0","summary":"Monopar says FDA grants rare pediatric disease designation for ALXN1840 in Wilson diseaseMonopar Therapeutics received FDA Rare Pediatric Disease designation for ALXN1840 to treat Wilson disease.The d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL3RVG8R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647977553","title":"Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for Alxn1840 for the Treatment of Wilson Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2647977553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647977553?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:00","pubTimestamp":1782820806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA6J8DYJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647303575","title":"Monopar Therapeutics is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2647303575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647303575?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:56","pubTimestamp":1782816960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MNPR/analyst-ratings(END) Dow Jones NewswiresJune 30, 2026 06:56 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647379100","title":"Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL) and Monopar Therapeutics Inc (MNPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647379100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647379100?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:50","pubTimestamp":1782733832,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Replimune Group (REPL) and Monopar Therapeutics Inc (MNPR). Repli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-replimune-group-repl-and-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-replimune-group-repl-and-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0128526141.USD","XLV","LABU","XBI","LU0029874061.USD","HCSG","BK4137","REPL","BK4581","BK4585","BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647177373","title":"Monopar Therapeutics Price Target Maintained with a $105.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2647177373","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647177373?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:36","pubTimestamp":1782729360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MNPR/analyst-ratings(END) Dow Jones NewswiresJune 29, 2026 06:36 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647351320","title":"Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647351320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647351320?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:30","pubTimestamp":1782725451,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-monopar-therapeutics-inc-mnpr-and-bio-techne-tech-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-monopar-therapeutics-inc-mnpr-and-bio-techne-tech-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3PB1722.GBP","BK4581","LU0432979614.USD","LABU","LU2023251221.USD","LU0211326755.USD","LU0070302665.USD","XBI","LU1571399168.USD","LU1061106388.HKD","LU1116320901.HKD","LU0006306889.USD","TECH","BK4566","IE00B64QTZ34.USD","LU2468319806.SGD","XLV","IE00BDGV0183.EUR","IE000M9KFDE8.USD","LU1023059063.AUD","LU0265550946.USD","BK4121","MDT","IE00BFXG1179.USD","LU0122379950.USD","LU0162691827.USD","BK4585","LU1116320737.USD","MNPR","LU2089284900.SGD","BK4139","IE00BVYPNW00.USD","BK4137","LU0320765489.SGD","BK4533","HCSG","LU2089283258.USD","IE00B42XCP33.USD","IE00B3T34201.USD","BK4082","LU2237957902.USD","LU1989764748.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","LU1989764664.SGD","LU0211331839.USD","IE00B19Z6F94.USD","LU2112291526.USD","LU1057294990.SGD","LU1506573853.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646360692","title":"Monopar Therapeutics announces new FoCus trial analyses","url":"https://stock-news.laohu8.com/highlight/detail?id=2646360692","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646360692?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:10","pubTimestamp":1782504622,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics (MNPR) announced that new analyses from the Phase 3 FoCus randomized controlled clinical trial of ALXN1840 will be presented a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/monopar-therapeutics-announces-new-focus-trial-analyses-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/monopar-therapeutics-announces-new-focus-trial-analyses-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646608623","title":"Monopar Says Phase 3 Focus Analysis Shows Alxn1840 Outperforms Standard Care in Neurologic Wilson Disease Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2646608623","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646608623?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:05","pubTimestamp":1782504326,"startTime":"0","endTime":"0","summary":"Monopar says Phase 3 FoCus analysis shows ALXN1840 outperforms standard care in neurologic Wilson disease patientsMonopar flagged new Phase 3 FoCus trial analyses of ALXN1840 in Wilson disease schedul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL8Ty8v3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","NDAQ","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","BK4139","IE00BN0W2V16.EUR","SG9999014021.USD","BK4588","IE00BN0W2T93.GBP","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645268835","title":"Monopar Therapeutics holds annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645268835","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645268835?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:01","pubTimestamp":1782216115,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics held its annual meeting on June 22, 2026.Shareholders backed the slate of director nominees, setting board membership until the next annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monopar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL6KZ274:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645008967","title":"Monopar Therapeutics management to meet virtually with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2645008967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645008967?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:05","pubTimestamp":1782162332,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held on June 23 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/monopar-therapeutics-management-to-meet-virtually-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/monopar-therapeutics-management-to-meet-virtually-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640910720","title":"Monopar Therapeutics Inc (MNPR) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2640910720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640910720?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:58","pubTimestamp":1780401520,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Monopar Therapeutics Inc today and set a price target of $101.00. According to TipRanks...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/monopar-therapeutics-inc-mnpr-receives-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/monopar-therapeutics-inc-mnpr-receives-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640633589","title":"Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), Gossamer Bio (GOSS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640633589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640633589?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:30","pubTimestamp":1780327821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monopar Therapeutics Inc (MNPR), Gossamer Bio (GOSS)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-monopar-therapeutics-inc-mnpr-gossamer-bio-goss-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-monopar-therapeutics-inc-mnpr-gossamer-bio-goss-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MNPR","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640204950","title":"Lake Street Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640204950","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640204950?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:26","pubTimestamp":1780323968,"startTime":"0","endTime":"0","summary":"In a report released today, Chad Messer from Lake Street maintained a Buy rating on Monopar Therapeutics Inc, with a price target of $103.00. Messe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640441955","title":"Monopar presents Phase 2 data showing ALXN1840 stabilizes liver disease in Wilson patients at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640441955","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640441955?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:04","pubTimestamp":1780311881,"startTime":"0","endTime":"0","summary":"Monopar highlighted Phase 2 ALXN1840 data already presented at EASL 2026 in treatment-experienced Wilson disease patients.The 48-week study showed liver disease generally stabilized, with some patients showing improvement on biopsy assessments.Patients also showed improvement in neurological symptoms, with gains in overall clinical status and reported quality of life.Safety was broadly consistent with tolerability expectations, with most side effects described as nonserious.The readout supports ALXN1840’s positioning for Wilson disease patients inadequately served by current standard therapies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL1HyH56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BGHQF748.EUR","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4139","BK4588","IE00BN0W2T93.GBP","NDAQ","LU2210149790.SGD","IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","SG9999014039.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636867567","title":"Monopar says Phase 2 trial shows ALXN1840 improves copper balance in Wilson disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2636867567","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636867567?lang=en_us&edition=fundamental","pubTime":"2026-05-20 05:27","pubTimestamp":1779226034,"startTime":"0","endTime":"0","summary":"Monopar flagged a newly published peer-reviewed Phase 2 open-label study on ALXN1840 in Wilson disease, with results already presented in the journal article.The trial showed the drug rapidly improved copper control versus patients’ pre-treatment baseline, supporting its potential to reduce harmful copper build-up over time.Investigators reported the effect was sustained during the study period, with the improvement driven by greater elimination of copper through the digestive tract.The treatment was generally well tolerated, with no serious adverse events reported.Monopar framed the findings as supportive of prior Phase 3 evidence that ALXN1840 can outperform current standard treatments even in long-treated patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDLccq9Vk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076306","title":"Analysts’ Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), Voyager Therapeutics (VYGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076306?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:00","pubTimestamp":1779109252,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monopar Therapeutics Inc (MNPR), Voyager Therapeutic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-monopar-therapeutics-inc-mnpr-voyager-therapeutics-vygr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-monopar-therapeutics-inc-mnpr-voyager-therapeutics-vygr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","MNPR","XBI","BK4137","VYGR","HCSG","BK4581","LU0029874061.USD","LU0128526141.USD","BK4139","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076802","title":"Morgan Stanley Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076802","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076802?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:00","pubTimestamp":1779109233,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Maxwell Skor maintained a Buy rating on Monopar Therapeutics Inc today and set a price target of $59.27. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-buy-rating-on-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-buy-rating-on-monopar-therapeutics-inc-mnpr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635085586","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635085586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635085586?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:40","pubTimestamp":1778841616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zenas BioPharma, Inc. (ZBIO), Monopar Therapeutics I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-173?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-173?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","XBI","LABU","BLSX","LU0128526141.USD","BK4139","ZBIO","BK4585","BLSG","BK4137","MNPR","BK4588","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.monopartx.com","stockEarnings":[{"period":"1week","weight":0.1159},{"period":"1month","weight":0.5963},{"period":"3month","weight":0.7738},{"period":"6month","weight":0.4814},{"period":"1year","weight":1.7813},{"period":"ytd","weight":0.4975}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.22612},{"month":2,"riseRate":0.285714,"avgChangeRate":0.090755},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.182533},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.03289},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.037743},{"month":6,"riseRate":0.714286,"avgChangeRate":0.099323},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.032851},{"month":8,"riseRate":0,"avgChangeRate":-0.159034},{"month":9,"riseRate":0.333333,"avgChangeRate":0.484161},{"month":10,"riseRate":0.5,"avgChangeRate":0.223985},{"month":11,"riseRate":0.666667,"avgChangeRate":0.047001},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.031256}],"exchange":"NASDAQ","name":"Monopar Therapeutics","nameEN":"Monopar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.1","shortVersion":"4.45.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monopar Therapeutics(MNPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monopar Therapeutics(MNPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monopar Therapeutics,MNPR,Monopar Therapeutics股票,Monopar Therapeutics股票老虎,Monopar Therapeutics股票老虎国际,Monopar Therapeutics行情,Monopar Therapeutics股票行情,Monopar Therapeutics股价,Monopar Therapeutics股市,Monopar Therapeutics股票价格,Monopar Therapeutics股票交易,Monopar Therapeutics股票购买,Monopar Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monopar Therapeutics(MNPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monopar Therapeutics(MNPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction